Drug concentrations and anti-drug antibodies during treatment with biosimilar infliximab (CT-P13) in routine care

Publikation: Bidrag til tidsskriftLetterForskningpeer review

  • B Glintborg
  • T Kringelbach
  • N Bolstad
  • D J Warren
  • G Eng
  • I J Sørensen
  • A G Loft
  • O Hendricks
  • Imj Hansen
  • A Linauskas
  • H Nordin
  • S Kristensen
  • H Lindegaard
  • D V Jensen
  • G L Goll
  • E Høgdall
  • J Gehin
  • C Enevold
  • C H Nielsen
  • N S Krogh
  • J S Johansen
  • M L Hetland

Detaljer

OriginalsprogEngelsk
TidsskriftScandinavian Journal of Rheumatology
Antal sider4
ISSN0300-9742
DOI
StatusE-pub ahead of print - 9 jan. 2018
PublikationsartForskning
Peer reviewJa
ID: 267511044